Answers are grounded in this paper and cite their sources.
Shows that low-density lipoprotein apheresis improves microcirculation and suppresses oxidative stress in peripheral arterial disease, suggesting potential to halt atherosclerosis progression.
Low-density lipoprotein apheresis (LDLA) leads to an improvement of microcirculation during the very early stages of treatment, and continued treatment may produce antiatherogenic effects in patients with peripheral arterial disease (PAD). Suppression of oxidative stress, improvement of endothelial functions and alteration in the action of vasoactive compounds may occur with the improvement of the rheological property of blood as a result of aggressive removal of atherogenic factors including LDL, possibly resulting in the suppression of development of atherosclerosis. As these effects of LDLA may ameliorate not only PAD but also ischemia in other organs, it is suggested that repeated LDLA prevents the progression of atherosclerotic diseases and probably improves the long-term prognosis of patients with PAD.
No takes yet. Share an insight, caveat, or question.
Sato et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: